GlassScriptPhysician profile
Deepak K Naidu
NPI 1497707947
$2,819.15
in general payments reported to CMS, 2019-2025
14 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $174 · 2022: $927 · 2023: $739 · 2024: $559 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.84 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $744.89 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $643.60 | 2021-2022 | |
| Abbvie INC. | $408.41 | 2023-2025 | |
| Integra Lifesciences Corporation | $213.86 | 2019-2022 | |
| Innovation Technologies INC | $176.13 | 2022 | |
| Rti Surgical, INC | $168.92 | 2023-2025 | |
| Baxter Healthcare | $124.15 | 2024 | Artiss |
| Smith+Nephew, INC. | $63.47 | 2022-2024 | Pico 14 |
| Davol INC. | $57.00 | 2025 | |
| Sanara Medtech INC. | $56.41 | 2022 | |
| Medtronic, INC. | $50.97 | 2021 | |
| Motiva USA, LLC | $47.18 | 2024 | |
| Depuy Synthes Sales INC. | $36.47 | 2023 | Xcm Biologic Tissue Matrix |
| Mentor Worldwide LLC | $27.69 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Naidu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.